⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methyl Alcohol SCHEMBL6832438 | 0.98 | — | — | |
| SCHEMBL1665467 | 0.86 | — | — | |
| SCHEMBL1030937 | 0.86 | — | — | |
| SCHEMBL1665420 | 0.83 | — | — | |
| SCHEMBL17593230 | 0.78 | — | — | |
| SCHEMBL3212979 | 0.67 | — | — | |
| Ethane SCHEMBL27535133 | 0.67 | — | — | |
| SCHEMBL4254172 | 0.67 | — | — | |
| SCHEMBL28815353 | 0.67 | — | — | |
| SCHEMBL27801237 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180221508-A1 | COMPOSITIONS AND METHODS FOR IMMUNOMODULATION | TVA (ABC), LLC | 2018-08-09 | — | — | US | claimed |
| US-20180221503-A1 | COMPOSITIONS AND METHODS FOR IMMUNO-ONCOLOGY THERAPIES | TVA (ABC), LLC | 2018-08-09 | — | — | US | claimed |
| EP-3328363-A1 | COMPOSITIONS AND METHODS FOR IMMUNOMODULATION | Tarveda Therapeutics, Inc. (US) | 2018-06-06 | — | — | EP | claimed |
| EP-3328377-A1 | COMPOSITIONS AND METHODS FOR IMMUNO-ONCOLOGY THERAPIES | Tarveda Therapeutics, Inc. (US) | 2018-06-06 | — | — | EP | claimed |
| WO-2017023749-A1 | COMPOSITIONS AND METHODS FOR IMMUNOMODULATION | TARVEDA THERAPEUTICS, INC. (US) | 2017-02-09 | — | — | WO | claimed |
| WO-2017023779-A1 | COMPOSITIONS AND METHODS FOR IMMUNO-ONCOLOGY THERAPIES | TARVEDA THERAPEUTICS, INC. (US) | 2017-02-09 | — | — | WO | claimed |
| EP-0871673-B1 | BISPECIFIC ANTIBODIES IN WHICH THE BINDING CAPABILITY IS REVERSIBLY INHIBITED BY A PHOTOCLEAVABLE MOIETY | BIOENHANCEMENTS LTD (GB) | 2006-04-05 | — | — | EP | claimed |
| US-20040197336-A1 | Bispecific antibodies in which the binding capability is reversibly inhibited by a photocleavable moiety | SELF COLIN HENRY (GB) | 2004-10-07 | — | — | US | claimed |
| EP-0871673-A1 | BISPECIFIC ANTIBODIES IN WHICH THE BINDING CAPABILITY IS REVERSIBLY INHIBITED BY A PHOTOCLEAVABLE MOIETY | Bioenhancementsments Ltd. (GB) | 1998-10-21 | — | — | EP | claimed |
| WO-1996034892-A1 | BISPECIFIC ANTIBODIES IN WHICH THE BINDING CAPABILITY IS REVERSIBLY INHIBITED BY A PHOTOCLEAVABLE MOIETY | BIOENHANCEMENTS LTD. (GB) | 1996-11-07 | — | — | WO | claimed |
| US-20180221503-A1 | COMPOSITIONS AND METHODS FOR IMMUNO-ONCOLOGY THERAPIES | TVA (ABC), LLC | 2018-08-09 | — | — | US | disclosed |
| US-20180221508-A1 | COMPOSITIONS AND METHODS FOR IMMUNOMODULATION | TVA (ABC), LLC | 2018-08-09 | — | — | US | disclosed |
| EP-3328363-A1 | COMPOSITIONS AND METHODS FOR IMMUNOMODULATION | Tarveda Therapeutics, Inc. (US) | 2018-06-06 | — | — | EP | disclosed |
| EP-3328377-A1 | COMPOSITIONS AND METHODS FOR IMMUNO-ONCOLOGY THERAPIES | Tarveda Therapeutics, Inc. (US) | 2018-06-06 | — | — | EP | disclosed |
| WO-2017023749-A1 | COMPOSITIONS AND METHODS FOR IMMUNOMODULATION | TARVEDA THERAPEUTICS, INC. (US) | 2017-02-09 | — | — | WO | disclosed |
| EP-1723418-A2 | BINDING AGENTS | Bioenhancementsments Ltd. (GB) | 2006-11-22 | — | — | EP | disclosed |
| EP-0871673-B1 | BISPECIFIC ANTIBODIES IN WHICH THE BINDING CAPABILITY IS REVERSIBLY INHIBITED BY A PHOTOCLEAVABLE MOIETY | BIOENHANCEMENTS LTD (GB) | 2006-04-05 | — | — | EP | disclosed |
| WO-2005083431-A2 | BINDING AGENTS | BLOENHANCEMENTS LIMITED (GB) | 2005-09-09 | — | — | WO | disclosed |
| EP-0871673-A1 | BISPECIFIC ANTIBODIES IN WHICH THE BINDING CAPABILITY IS REVERSIBLY INHIBITED BY A PHOTOCLEAVABLE MOIETY | Bioenhancementsments Ltd. (GB) | 1998-10-21 | — | — | EP | disclosed |
| WO-1996034892-A1 | BISPECIFIC ANTIBODIES IN WHICH THE BINDING CAPABILITY IS REVERSIBLY INHIBITED BY A PHOTOCLEAVABLE MOIETY | BIOENHANCEMENTS LTD. (GB) | 1996-11-07 | — | — | WO | disclosed |